No earnings forecast score is currently available for Cosmos Health Inc. The Pharmaceuticals industry's average is 7.87. The average price target is 3.00, with a high of 3.00 and a low of 3.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
4.500
Target Price
+2363.05%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Cosmos Health Inc
COSM
0
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cosmos Health Inc's expected revenue for the next quarter?
Cosmos Health Inc's expected revenue is 19.42M.
What is Cosmos Health Inc's price target?
Analysts forecast that Cosmos Health Inc's price target is USD 3.00, with the highest forecast at USD 3.00 and the lowest forecast at USD 3.00.
How have Cosmos Health IncCOSM's recent earnings per share performed?
The market expectation was USD -0.06, while Cosmos Health IncCOSM's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD 0.01.